Angel News

Angel News

Back to Homepage

20th March 2019

Leading neuro-tech firm Neurovalens raises £4.6 million

Belfast-based health tech company, Neurovalens, has secured one of the largest ever Series A investments generated by a Northern Irish technology company.

The company specialises in using neuroscience to solve everyday health issues.

The £4.6 million raise was led by London-based Wharton Asset Management along with Cambridge based IQ Capital. The round was also supported by Techstart Ventures, through its Invest NI-backed fund, The UU Fund, Co-Fund NI managed by Clarendon Fund Management, Beltrae Partners and the Angel CoFund.

18th March 2019

Downing FOUR VCT Healthcare open for tax year-end investments

As the tax year draws to a close, the Downing FOUR Venture Capital Trust (VCT) Healthcare Share Class remains open for end of year tax investments as part of a £10.2m top-up offer.

7th March 2019

Global Venture Partners backs veterinary tech business Felcana

London-based veterinary tech business, Felcana, has received an early stage venture capital investment from Global Venture Partners and Seedrs. The terms of the transaction were not disclosed.

Founded in 2016 by veterinary professionals, Felcana combines artificial intelligence, data analytics and veterinary expertise to help predict, simplify and treat over 90% of health issues for dogs and cats. Felcana will use the fresh capital to expand its presence in the UK and to scale internationally.

 

6th March 2019

Beauhurst report maps UK Life Sciences landscape

Beauhurst has outlined the UK’s Life Sciences landscape and provided a downloadable spreadsheet of the top companies in the sector – by amount of funding received, percentage growth in turnover and latest valuation. 

5th March 2019

AdoRx collaborates with Johnson & Johnson Innovation

AdoRx Therapeutics, a UK based drug discovery company, has announced that it has entered into a strategic collaboration with Johnson & Johnson Innovation LLC* and the Lung Cancer Initiative at Johnson & Johnson to develop novel therapeutics for the treatment of lung cancer. 

14th February 2019

Resonance backs social enterprise Memory Matters

Award winning, social enterprise Memory Matters CIC, which runs the Moments Café in the heart of Plymouth, has received investment of £100,000 to franchise its innovative training package enabling it to be delivered to more people.  The investment came from the Health & Wellbeing Challenge Fund (South West) (H&WCF), managed by social impact investment company Resonance.

12th February 2019

Angel backed PBD Biotech wins Royal Dairy Innovation Award 2019

Angel-backed company PBD Biotech has had its novel Actiphage® testing technology named as the winner of the Royal Dairy Innovation Award at Dairy-Tech 2019.

The Royal Dairy Innovation trophy and certificate are awarded for research and development in the field of dairy farming. With the award going to the most practical, relevant product, which is likely to be the most significant innovation for the future of dairying.

11th February 2019

Forth secures investment from Development Bank of Wales

Innovative biometric tracking service, Forth, which helps people to navigate their way to better health using simply at-home finger-prick blood tests, has secured new investment from its first institutional investor.  The new investment came from The Development Bank of Wales, together with a group of angels from Angels Invest Wales and South West based angel investors, including Craig Gulliford, CEO of Creo Medical.

Gulliford, who was an early investor in the company during its first raise on Crowdcube in 2017 and has since joined the board, said: “I have an affinity for technology-based companies that have an innovative and disruptive proposition backed by great people. Forth ticks this box and the management team crucially also have the energy, passion, determination to succeed at all costs”.

1st February 2019

UK medicinal marijuana startups take off says Beauhurst report

Last July, Oxford Cannabinoid Technologies raised $10m in equity finance. This was a significant moment in the UK’s investment scene, representing the first equity investment into a medicinal marijuana startup in nearly two decades (since GW Pharmaceuticals listed on the AIM in 2001).

Given the increasing noise about the potential of cannabis-derived drugs, and the increasingly soft stance of Home Secretary Sajid Javid, we predicted that this sector was on the tipping point of an investment “green rush”.

Our predictions have so far been borne out. Later in July Grow Biotech raised £2m in equity finance, at a £14m pre-money valuation. Under the helm of Ben Langley, an ex-Morgan Stanley trader, Grow Biotech is looking to bridge the gap between science and market in the medicinal marijuana sector. Essentially, they are looking to develop pharmaceutical IP, based on cannabis-derived compounds. Currently, they are in their R&D phase.

30th January 2019

Newable exits investment in Hallmarq
Newable Private Investing syndicate including the LBA EIS Tracker Fund 4 make greater than 5x return following Hallmarq Veterinary Imaging’s management buyout.

Hallmarq Veterinary Imaging, a global specialist in advanced diagnostics for equine and companion animals, has successfully completed a management buyout led by mid market private equity firm August Equity. As a result of the deal, NPI Investors as well as the LBA EIS Tracker Fund 4 have made a greater than 5x return on their investment.

30th January 2019

Resonance helps Smile Together raise £1m

Resonance, a social impact investment company, with a head office in Cornwall, worked with Smile Together as advisers on the investment raise.

BII, the social investment arm of The Big Issue, provided investment to Smile Together CIC, a local employee-owned social enterprise and Community Interest Company, in late 2018. The investment is helping to finance the refurbishment of a former grammar school into a purpose-built dental centre for the community.

The opening of the centre, located on Harleigh Road in Bodmin Cornwall, will increase access to emergency, specialist and routine dental care, provide enhanced access and facilities for all patient groups, and also increase the availability of preventative support, education and treatment programmes. An adjoining part of the building will eventually house other local businesses, promoting further financial sustainability for Smile Together.

28th January 2019

Foresight backs Fertility Focus with £1.25 million investment

Foresight Group has made a £1.25 million growth capital investment into Fertility Focus Limited, a leading fertility monitoring technology company that has developed OvuSense, a registered medical device that enables women to predict ovulation.  The investment was led by Foresight on behalf of Foresight VCT plc and Foresight 4 VCT plc as part of a larger £2 million funding round, supported by new and existing investors including private High Net-Worth Individuals.

Items of 122NEXT

Back to Homepage